Safety and Durability of Ponatinib in Patients With Philadelphia Chromosome–Positive (Ph+) Leukemia: Long-term Follow-up of an Ongoing Phase 1 Study
Titel:
Safety and Durability of Ponatinib in Patients With Philadelphia Chromosome–Positive (Ph+) Leukemia: Long-term Follow-up of an Ongoing Phase 1 Study
Auteur:
Mauro, Michael J. Cortes, Jorge E. Kantarjian, Hagop M. Shah, Neil P. Bixby, Dale Flinn, Ian W. O’Hare, Thomas Hu, Simin Rivera, Victor M. Clackson, Tim Turner, Christopher D. Haluska, Frank G. Druker, Brian J. Deininger, Michael W. Talpaz, Moshe